Get the Stockscreener App
3.05
0.97%
-0.03
After Hours:
2.94
-0.11
-3.61%
Gossamer Bio Inc stock is traded at $3.05, with a volume of 5.10M.
It is down -0.97% in the last 24 hours and up +58.85% over the past month.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
See More
Previous Close:
$3.08
Open:
$3.13
24h Volume:
5.10M
Relative Volume:
1.45
Market Cap:
$693.51M
Revenue:
-
Net Income/Loss:
$-179.82M
P/E Ratio:
-2.2932
EPS:
-1.33
Net Cash Flow:
$-159.16M
1W Performance:
-11.85%
1M Performance:
+58.85%
6M Performance:
+124.26%
1Y Performance:
+217.77%
1-Day Range:
$2.94
$3.18
1-Week Range:
$2.93
$3.55
52-Week Range:
$0.6617
$3.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Name
Gossamer Bio Inc
Sector
Industry
Phone
(858) 684-1300
Address
3115 MERRYFIELD ROW, SAN DIEGO, CA
Compare GOSS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
3.05 | 700.33M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-25 | Upgrade | UBS | Neutral → Buy |
| Jul-14-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Apr-05-24 | Resumed | Wedbush | Outperform |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Mar-07-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Dec-07-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-07-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-07-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-20-22 | Initiated | Goldman | Buy |
| Sep-21-22 | Initiated | JP Morgan | Neutral |
| Sep-19-22 | Initiated | Wedbush | Outperform |
| Apr-18-22 | Initiated | Raymond James | Outperform |
| Apr-06-22 | Initiated | UBS | Buy |
| Jan-10-22 | Upgrade | SMBC Nikko | Neutral → Outperform |
| Nov-09-21 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-21-21 | Resumed | Piper Sandler | Overweight |
| Jun-29-20 | Initiated | H.C. Wainwright | Buy |
| Apr-22-20 | Initiated | Piper Sandler | Overweight |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-30-19 | Initiated | Berenberg | Buy |
| Mar-05-19 | Initiated | Barclays | Overweight |
| Mar-05-19 | Initiated | BofA/Merrill | Buy |
| Mar-05-19 | Initiated | Evercore ISI | Outperform |
| Mar-05-19 | Initiated | SVB Leerink | Outperform |
View All
Gossamer Bio Inc Stock (GOSS) Latest News
Surprises Report: Is Gossamer Bio Inc stock heavily shortedRate Hike & Capital Efficiency Focused Strategies - khodrobank.com
Can volume confirm reversal in Gossamer Bio Inc.Earnings Summary Report & Breakout Confirmation Alerts - newser.com
Patterns Watch: How cyclical is Gossamer Bio Inc.’s revenue streamWeekly Gains Summary & Fast Entry and Exit Trade Plans - khodrobank.com
Real time breakdown of Gossamer Bio Inc. stock performanceQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Gossamer Bio (NASDAQ:GOSS) Trading Down 5%What's Next? - MarketBeat
Ideas Watch: How liquid is Gossamer Bio Inc. stockTrade Volume Summary & High Yield Stock Recommendations - khodrobank.com
Gossamer Bio Inc. stock trendline breakdownTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Aug Retail: Does Gossamer Bio Inc. have a sustainable dividendTrade Ideas & Daily Growth Stock Tips - khodrobank.com
Aug Analyst Calls: How cyclical is Gossamer Bio Incs revenue streamJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - khodrobank.com
Acadian Asset Management LLC Buys 1,253,353 Shares of Gossamer Bio, Inc. $GOSS - MarketBeat
What technical models suggest about Gossamer Bio Inc.’s comebackEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Investor Mood: What is the long term forecast for Gossamer Bio Inc stockEarnings Trend Report & Weekly High Potential Alerts - khodrobank.com
Gossamer Bio Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Gossamer Bio (NASDAQ:GOSS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evaluating Gossamer Bio Inc. with trendline analysisJuly 2025 Technicals & Community Supported Trade Ideas - newser.com
Top chart patterns to watch in Gossamer Bio Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
FOMO Trade: Is Gossamer Bio Inc stock a smart retirement pick2025 EndofYear Setup & Safe Investment Capital Preservation Plans - khodrobank.com
Gossamer Bio (NASDAQ:GOSS) Shares Gap UpHere's Why - MarketBeat
Aug Wrap: Is Gossamer Bio Inc in a long term uptrendWeekly Investment Recap & Real-Time Buy Signal Alerts - khodrobank.com
What candlestick patterns are forming on Gossamer Bio Inc.2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Rally Mode: Does Gossamer Bio Inc stock benefit from AI growthJuly 2025 Closing Moves & Trade Opportunity Analysis - khodrobank.com
Using Bollinger Bands to evaluate Gossamer Bio Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Relative strength of Gossamer Bio Inc. in sector analysisJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
How to build a dashboard for Gossamer Bio Inc. stockWeekly Volume Report & Free Community Consensus Stock Picks - newser.com
H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS) - MSN
Siren L.L.C. Reduces Holdings in Gossamer Bio, Inc. $GOSS - MarketBeat
Treasury Yields: Is Gossamer Bio Inc in a long term uptrendJuly 2025 Highlights & Real-Time Volume Surge Alerts - khodrobank.com
US Market Recap: Is Gossamer Bio Inc. stock a smart retirement pickEarnings Overview Report & Stepwise Swing Trade Plans - khodrobank.com
Dip Buying: What is the long term forecast for Gossamer Bio Inc stockJuly 2025 Levels & Risk Controlled Swing Alerts - خودرو بانک
Gossamer Bio stock maintains Buy rating at H.C. Wainwright with $10 price target - Investing.com India
Quantitative breakdown of Gossamer Bio Inc. recent move2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Brokerages Set Gossamer Bio, Inc. (NASDAQ:GOSS) Price Target at $8.50 - MarketBeat
Published on: 2025-09-16 13:34:28 - khodrobank.com
Gossamer Bio (NASDAQ:GOSS) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Trading Action: Should I set a stop loss on Gossamer Bio IncJuly 2025 Reactions & Weekly Top Stock Performers List - khodrobank.com
How to integrate Gossamer Bio Inc. into portfolio analysis toolsWeekly Risk Report & Trade Opportunity Analysis Reports - newser.com
Gossamer Bio Sees Unusually Large Options Volume (NASDAQ:GOSS) - MarketBeat
Update Recap: Does Gossamer Bio Inc. have a sustainable dividendJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - khodrobank.com
Is Gossamer Bio Inc. forming bullish engulfing patternsWeekly Stock Recap & Weekly High Return Stock Opportunities - خودرو بانک
FOMO Trade: Is Gossamer Bio Inc part of any ETFWeekly Trading Summary & Intraday High Probability Setup Alerts - خودرو بانک
Gossamer Bio (GOSS): Assessing Valuation After Encouraging Phase 2 Data and Analyst Optimism - Yahoo
Gossamer Bio (NASDAQ:GOSS) Reaches New 12-Month HighStill a Buy? - MarketBeat
Key resistance and support levels for Gossamer Bio Inc.July 2025 Volume & Fast Gaining Stock Reports - newser.com
Gossamer Bio Inc Stock (GOSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):